278 related articles for article (PubMed ID: 31077558)
21. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
22. Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.
Arlindo EM; Marcondes NA; Fernandes FB; Faulhaber GAM
Rev Bras Hematol Hemoter; 2017; 39(3):252-258. PubMed ID: 28830605
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
Langabeer SE; O'Brien D; Liptrot S; Flynn CM; Hayden PJ; Conneally E; Browne PV; Vandenberghe E
Int J Lab Hematol; 2012 Aug; 34(4):417-21. PubMed ID: 22313586
[TBL] [Abstract][Full Text] [Related]
24. V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia.
Arora N; Nair S; Pai R; Nair S; Ahmed R; Abraham A; Viswabandya A; George B; Balasubramanian P; Srivastava A; Mathews V
Indian J Pathol Microbiol; 2015; 58(1):62-5. PubMed ID: 25673595
[TBL] [Abstract][Full Text] [Related]
25. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
26. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.
Arons E; Suntum T; Stetler-Stevenson M; Kreitman RJ
Blood; 2009 Nov; 114(21):4687-95. PubMed ID: 19745070
[TBL] [Abstract][Full Text] [Related]
27. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
28. Molecular variant of hairy cell leukemia with poor prognosis.
Arons E; Kreitman RJ
Leuk Lymphoma; 2011 Jun; 52 Suppl 2(Suppl 2):99-102. PubMed ID: 21599610
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
30. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
[TBL] [Abstract][Full Text] [Related]
31. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
[No Abstract] [Full Text] [Related]
32. A case of hairy cell leukemia variant.
Găman AM; Dobrea CM; Găman MA
Rom J Morphol Embryol; 2015; 56(2):553-6. PubMed ID: 26193228
[TBL] [Abstract][Full Text] [Related]
33. Update on hairy cell leukemia.
Kreitman RJ; Arons E
Clin Adv Hematol Oncol; 2018 Mar; 16(3):205-215. PubMed ID: 29742076
[TBL] [Abstract][Full Text] [Related]
34. No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant.
King AC; Kabel CC; Pappacena JJ; Stump SE; Daley RJ
Ann Pharmacother; 2019 Sep; 53(9):922-932. PubMed ID: 30841702
[No Abstract] [Full Text] [Related]
35. CD5 positive hairy cell leukemia: A rare case report with brief review of literature.
Jain D; Dorwal P; Gajendra S; Pande A; Mehra S; Sachdev R
Cytometry B Clin Cytom; 2016 Sep; 90(5):467-72. PubMed ID: 27129891
[TBL] [Abstract][Full Text] [Related]
36. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of hairy cell leukemia by flow cytometry.
Stetler-Stevenson M; Tembhare PR
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
40. Impact of telomere length on survival in classic and variant hairy cell leukemia.
Arons E; Zhou H; Edelman DC; Gomez A; Steinberg SM; Petersen D; Wang Y; Meltzer PS; Kreitman RJ
Leuk Res; 2015 Dec; 39(12):1360-6. PubMed ID: 26520623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
